Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14226 - 14250 of 14906 in total
Vitamin A-analog that increases diffusivity of oxygen in aqueous solutions, including plasma.
Investigational
Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. However, clinical trials have revealed that idraparinux had lead to bleeding. As a result, Sanofi stopped the development of the drug.
Investigational
Matched Description: … It was developed for the treatment and prevention of thromboembolic events. …
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Hydronidone has antifibrotic activity.
Investigational
Investigational
Experimental
Displaying drugs 14226 - 14250 of 14906 in total